Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Pharmaceutics International, Inc.
FDA Inspection
•Pharmaceutics International, Inc.•November 9, 2018

Pharmaceutics International, Inc. – FDA Inspection, Nov 9, 2018

Record Details

This FDA Inspection record concerns Pharmaceutics International, Inc., with an inspection on November 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Pharmaceutics International, Inc.
Inspection Date
November 9, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Alice S. Tsao (FDA Associated Person)
  • Alison N. Stieg (FDA Associated Person)
  • David A. Oluwo (FDA Associated Person)
  • James M. Simpson (Company Rep)
  • Michael Shanks (Issuing Officer)
  • Simone E. Pitts (FDA Associated Person)
View Company Profile

ID · f3ba1bae-6f2d-49d8-ad30-c59d2fe1ee3b

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1072073
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

11
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.113(b)Validation lacking for sterile drug products
  3. 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
  4. 21 CFR 211.165(b)Microbiological testing
  5. 21 CFR 211.192Investigations of discrepancies, failures
  6. 21 CFR 211.22(d)Procedures not in writing, fully followed
  7. 21 CFR 211.25(a)Training , Education , Experience overall
  8. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  9. 21 CFR 820.50Purchasing controls, Lack of or inadequate procedures
  10. 21 CFR 820.70(a)Production processes

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Pharmaceutics International, Inc.

10
DateClassificationOfficeProject area
March 6, 2026Not classifiedBaltimore District OfficeDrug Quality Assurance
June 12, 2024NAICenter for Devices and Radiological HealthCompliance: Devices
November 14, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 29, 2021VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 10, 2020NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for Pharmaceutics International, Inc.
  • FDA Inspection 1307080 - 2026-03-06
  • FDA Inspection 1244595 - 2024-06-12
  • FDA Inspection 1194409 - 2022-11-14
  • FDA Inspection 1155191 - 2021-09-29
  • FDA Inspection 1124545 - 2020-07-10

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmaceutics International, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.